OA06528A - 2-aminoalkyl-5-pyridinols, procédé pour leur préparation, compositions pharmaceutiques contenant ces composés et leurs utilisations thérapeutiques. - Google Patents

2-aminoalkyl-5-pyridinols, procédé pour leur préparation, compositions pharmaceutiques contenant ces composés et leurs utilisations thérapeutiques.

Info

Publication number
OA06528A
OA06528A OA57107A OA57107A OA06528A OA 06528 A OA06528 A OA 06528A OA 57107 A OA57107 A OA 57107A OA 57107 A OA57107 A OA 57107A OA 06528 A OA06528 A OA 06528A
Authority
OA
OAPI
Prior art keywords
formula
xii
compounds
preparation
pyridinols
Prior art date
Application number
OA57107A
Other languages
English (en)
French (fr)
Inventor
Renat Herbet Mizzoni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of OA06528A publication Critical patent/OA06528A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Building Environments (AREA)
  • Paper (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
OA57107A 1979-05-03 1980-05-03 2-aminoalkyl-5-pyridinols, procédé pour leur préparation, compositions pharmaceutiques contenant ces composés et leurs utilisations thérapeutiques. OA06528A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3566879A 1979-05-03 1979-05-03

Publications (1)

Publication Number Publication Date
OA06528A true OA06528A (fr) 1981-07-31

Family

ID=21884070

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57107A OA06528A (fr) 1979-05-03 1980-05-03 2-aminoalkyl-5-pyridinols, procédé pour leur préparation, compositions pharmaceutiques contenant ces composés et leurs utilisations thérapeutiques.

Country Status (19)

Country Link
EP (1) EP0019739B1 (hu)
JP (1) JPS55149260A (hu)
AT (1) ATE8501T1 (hu)
DD (1) DD150461A5 (hu)
DE (1) DE3068577D1 (hu)
DK (1) DK157540C (hu)
ES (1) ES8104229A1 (hu)
FI (1) FI70212C (hu)
GB (1) GB2050380B (hu)
GR (1) GR68206B (hu)
HU (1) HU181115B (hu)
IE (1) IE49712B1 (hu)
IL (1) IL59978A (hu)
MA (1) MA18964A1 (hu)
NO (1) NO154130C (hu)
OA (1) OA06528A (hu)
PL (1) PL223984A1 (hu)
PT (1) PT71176A (hu)
ZW (1) ZW9680A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746670A (en) * 1986-04-11 1988-05-24 Ciba-Geigy Corporation Use of 2-aminoalkyl-5-pyridinols as nootropic agents and antidepressants
JP4732662B2 (ja) * 2000-04-06 2011-07-27 セイコーインスツル株式会社 電子時計の電池保持構造

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
IE800899L (en) 1980-11-03
GB2050380B (en) 1983-07-20
NO154130C (no) 1986-07-23
IL59978A (en) 1984-03-30
HU181115B (en) 1983-06-28
DD150461A5 (de) 1981-09-02
FI70212B (fi) 1986-02-28
MA18964A1 (fr) 1980-12-31
DK157540B (da) 1990-01-22
PL223984A1 (hu) 1981-02-13
PT71176A (en) 1980-05-01
JPS55149260A (en) 1980-11-20
FI70212C (fi) 1986-09-15
DK157540C (da) 1990-06-11
ZW9680A1 (en) 1980-11-26
IE49712B1 (en) 1985-11-27
GR68206B (hu) 1981-11-10
DE3068577D1 (en) 1984-08-23
GB2050380A (en) 1981-01-07
ES491055A0 (es) 1981-04-01
FI801411A (fi) 1980-11-04
NO801267L (no) 1980-11-04
IL59978A0 (en) 1980-07-31
DK193180A (da) 1980-11-04
EP0019739B1 (de) 1984-07-18
ATE8501T1 (de) 1984-08-15
EP0019739A1 (de) 1980-12-10
JPS6365662B2 (hu) 1988-12-16
ES8104229A1 (es) 1981-04-01
NO154130B (no) 1986-04-14

Similar Documents

Publication Publication Date Title
JPS56167643A (en) Mannich base hydroxamic acid precursor drug for improving transmission of non-steroid antiinflammatory
PT76316B (en) Process for the preparation of esters of substituted pyridino- 3,5-dicarboxylic and/or of pyrano-3,5-dicarboxylic acids having an hypotensive effect and application thereof for the preparation of pharmaceutical compositions having an hypotensive effect
PH24176A (en) New bicyclic compounds,process for preparation thereof and pharmaceutical composition comprising the same
OA06528A (fr) 2-aminoalkyl-5-pyridinols, procédé pour leur préparation, compositions pharmaceutiques contenant ces composés et leurs utilisations thérapeutiques.
FR2365566A1 (fr) Nouveaux derives du thiophene utiles comme medicaments
FR2362841A1 (fr) Derives d'acides heterocyclyl-carboxyliques acyles utiles comme medicaments et procede pour leur preparation
FR2355011A1 (fr) 2-imino-3-aminothiazolidines utiles comme medicaments
ES8104309A1 (es) Procedimiento para preparar enaminas
FR2388811A1 (fr) 3-(1-piperazinyl)-pyrido(2,3-b)pyrazines utiles comme medicaments
ES8401059A1 (es) Procedimiento para la preparacion de fenoleteres biciclicos.
GB871235A (en) Novel substituted pyrrolidones and salts thereof and a process for the manufacture of same
DE3063105D1 (en) Clavulanic acid derivatives, process for their preparation and pharmaceutical compositions containing them
GB1034192A (en) New pyrrolidino derivatives of acetamide
ES478502A1 (es) Un procedimiento para la preparacion de nuevas n-(piridotie-nopirazol)amidas